No Result
View All Result
No Result
View All Result
No Result
View All Result

Catalase | Ingredient Overview: Pharmacokinetics, Formulations, Human Research Evidence, Safety, and Combinations

by SHIZAM Editorial Team
April 19, 2026

Catalase is an endogenous antioxidant enzyme that catalyzes the breakdown of hydrogen peroxide into water and oxygen, occurring naturally in human cells and studied in human research primarily for its role in oxidative stress and skin-related conditions such as vitiligo. (Research)

Catalase is widely recognized as a core component of the body’s antioxidant defense system, helping regulate reactive oxygen species such as hydrogen peroxide. Human research has focused mainly on dermatological conditions, especially vitiligo, where oxidative imbalance has been observed, although findings from clinical trials are mixed and often involve catalase-containing combinations rather than isolated catalase. Evidence outside of skin-related research remains limited, and most mechanistic understanding comes from biochemical and observational studies. (Research) (Review)

Ingredient Snapshot

  • Classification: Antioxidant enzyme (Review)
  • Endogenous vs exogenous: Endogenously produced in human cells (Review)
  • Primary human research domains: Skin depigmentation disorders (vitiligo), oxidative stress biomarkers (Research)
  • Common study formats: Case-control studies, randomized trials (topical combinations), open-label clinical studies (Research)
  • Pharmacokinetic characterization status: Limited direct human PK data available
  • Regulatory context (U.S./EU): Not approved as a drug; studied primarily as a biological enzyme
  • Evidence maturity: Limited and condition-specific, with mixed clinical findings (Research)

Introduction

Catalase is a naturally occurring enzyme found in nearly all oxygen-exposed cells, where it plays a central role in breaking down hydrogen peroxide, a potentially harmful byproduct of cellular metabolism. It is particularly abundant in organs such as the liver and in red blood cells, reflecting its importance in managing oxidative stress. (Review)

Interest in catalase as an ingredient has emerged from research linking oxidative stress to various health conditions, especially vitiligo, where reduced catalase activity has been observed. Human studies have examined both endogenous catalase levels and topical or combination therapies aimed at restoring antioxidant balance, although results have varied and are often limited to specific clinical contexts. (Research) (Research)

This article is informational only, describes catalase as a biochemical substance studied in human research, and does not provide medical or dosing advice.

Quick Summary

  • Catalase is an endogenous antioxidant enzyme that breaks down hydrogen peroxide into water and oxygen, helping regulate oxidative stress in human cells. (Review)
  • Human research on catalase has focused mainly on skin conditions such as vitiligo, where oxidative imbalance and reduced catalase activity have been observed. (Research)
  • Clinical studies using topical catalase or pseudocatalase in vitiligo have reported mixed results, with some trials showing repigmentation and others finding no added benefit. (Research)
  • Observational studies consistently report lower catalase levels in individuals with vitiligo compared to controls, suggesting a role in disease-related oxidative stress. (Research)
  • Most human studies involve catalase in combination with other antioxidants or therapies, limiting conclusions about isolated catalase effects. (Research)
  • Evidence outside dermatology remains limited, and broader health applications are primarily supported by mechanistic or experimental research. (Review)

Human Research Findings by Condition

Beauty and Skin Health

Human research on catalase has largely focused on vitiligo, a condition characterized by loss of skin pigmentation. Studies have included randomized trials, open-label studies, and observational analyses, with mixed findings regarding topical catalase or pseudocatalase therapies. (Research)

Key human study

Dose studied: Topical pseudocatalase cream + NB-UVB
Population: Patients with active vitiligo
Duration: 24 weeks

This randomized double-blind placebo-controlled trial evaluated whether pseudocatalase cream added benefit to narrowband UVB therapy. While UVB treatment showed moderate effectiveness, the addition of pseudocatalase did not significantly improve outcomes compared to placebo cream.

Result: Human clinical study reported no clear effect
Evidence strength: Moderate

Study source: (Research)

Additional human study

Dose studied: Topical catalase + superoxide dismutase gel
Population: 22 vitiligo patients
Duration: 6 months

This clinical study assessed a topical gel containing catalase and superoxide dismutase combined with UV therapy. Approximately half of participants experienced more than 50% repigmentation, although the study was uncontrolled and small.

Result: Human clinical study reported a modest improvement
Evidence strength: Limited

Study source: (Research)

Immune System

Human studies have explored catalase primarily as part of oxidative stress pathways rather than as a direct immune-modulating therapy. Observational and case-control studies suggest altered antioxidant enzyme levels in certain immune-related conditions such as vitiligo. (Review)

Key human study

Dose studied: Not applicable (endogenous enzyme levels)
Population: Vitiligo patients vs controls
Duration: Cross-sectional

This case-control study measured serum and tissue catalase levels and found significantly lower levels in individuals with vitiligo compared to controls, supporting a role for oxidative stress in disease mechanisms.

Result: Observational human studies reported an association
Evidence strength: Observational

Study source: (Research)

Aging and Longevity Research

Research on catalase in aging has largely focused on oxidative stress biology, with human evidence primarily observational or mechanistic. Direct clinical trials targeting aging outcomes with catalase supplementation are lacking. (Review)

Key human study

Dose studied: Not applicable
Population: Human oxidative stress studies (indirect)
Duration: Variable

Human research indicates that catalase activity is part of the body’s defense against oxidative damage, which has been implicated in aging processes, although direct interventional evidence is limited.

Result: Human evidence remains limited or inconclusive
Evidence strength: Limited

Study source: (Review)

Endocrine Health

Catalase has been studied in relation to metabolic and oxidative stress pathways that intersect with endocrine function, though human evidence is indirect and limited.

Key human study

Dose studied: Not applicable
Population: Vitiligo-related oxidative stress cohorts
Duration: Cross-sectional

Studies examining oxidative stress markers, including catalase, suggest broader systemic involvement in conditions with endocrine and metabolic components, though causality is not established.

Result: Observational human studies reported an association
Evidence strength: Observational

Study source: (Research)

Cancer Research

Catalase has been investigated in the context of oxidative stress and cancer biology, but human clinical evidence directly evaluating catalase as an intervention is limited.

Key human study

Dose studied: Not applicable
Population: Human observational and mechanistic studies
Duration: Variable

Research has explored catalase activity as part of antioxidant defense in cancer-related oxidative stress, but clinical trials targeting cancer outcomes are lacking.

Result: Human evidence remains limited or inconclusive
Evidence strength: Limited

Study source: (Review)

Hair Pigmentation Biology

Human research has explored catalase in relation to hair pigmentation, particularly in the context of age-related graying. Observational and biochemical studies have reported accumulation of hydrogen peroxide within hair follicles, which may impair melanocyte function and reduce melanin production. (Research) (Review)

Catalase is part of the endogenous antioxidant system responsible for breaking down hydrogen peroxide. Reduced catalase activity has been observed in gray or depigmented hair follicles, suggesting a role in oxidative stress–related pigment loss. (Research) (Review)

Key human study

Dose studied: Not applicable (endogenous enzyme activity)
Population: Human hair shaft and follicle analysis (pigmented vs gray hair)
Duration: Cross-sectional / laboratory-based

Human biochemical studies have identified elevated hydrogen peroxide levels in gray hair shafts alongside reduced catalase activity. These findings suggest that oxidative accumulation within the follicle environment may interfere with melanocyte function and melanin synthesis.

Result: Observational human studies reported an association
Evidence strength: Observational

Study source: (Research)

Notes / limitations: Findings are based on biochemical and observational data and do not establish causality or therapeutic effect

Dosage & Study Snapshot (Research Context)

Human research on catalase primarily involves topical formulations and endogenous enzyme measurements, rather than standardized oral supplementation. Most studies examine catalase in combination therapies or as a biomarker of oxidative stress.

Endogenous catalase levels (biomarker studies):

Catalase is measured in serum or tissue samples in observational studies. In vitiligo populations, reduced catalase levels have been consistently reported, indicating impaired antioxidant capacity. These studies are cross-sectional and do not involve administered doses.

Result: Observational association
Evidence strength: Observational

Notes / limitations: Does not establish causality or therapeutic effect

(Research)

Topical pseudocatalase (with UV therapy):

Topical pseudocatalase formulations have been applied alongside UVB therapy in vitiligo studies. Some early uncontrolled studies reported repigmentation, but randomized trials have not consistently shown added benefit over UV therapy alone.

Result: Mixed findings
Evidence strength: Moderate

Notes / limitations: Effects may depend on combination therapy rather than catalase alone

(Research)

Topical catalase + antioxidant combinations:

Studies using catalase combined with superoxide dismutase in gel formulations have reported partial repigmentation in some patients. These studies are typically small and lack control groups.

Result: Modest improvement
Evidence strength: Limited

Notes / limitations: Cannot isolate catalase-specific effects

(Research)

Pilot topical antioxidant enzyme therapies:

Small randomized or pilot studies evaluating catalase-based antioxidant gels have reported no significant benefit compared to placebo in some cases, highlighting variability in outcomes.

Result: No clear effect
Evidence strength: Limited

Notes / limitations: Small sample sizes and formulation differences

(Research)

Key Takeaways from Human Research

  • Human evidence for catalase is strongest in vitiligo-related skin research, but results are mixed across randomized and observational studies. (Research)
  • Lower catalase levels are consistently observed in individuals with vitiligo, suggesting a role in oxidative stress pathways. (Research)
  • Topical catalase or pseudocatalase therapies show variable effectiveness, with some studies reporting improvement and others no additional benefit. (Research)
  • Most studies use catalase in combination with other antioxidants or treatments, limiting conclusions about its independent effects. (Research)
  • Evidence for systemic or non-dermatological uses remains limited and largely mechanistic. (Review)

Ingredient Identity

  • Official name: Catalase
  • Synonyms: Hydrogen peroxide oxidoreductase
  • Classification: Antioxidant enzyme
  • CAS number: 9001-05-2
  • Endogenous vs exogenous: Endogenous

Origin & Natural Occurrence

Catalase is produced naturally in the human body and is found in nearly all aerobic organisms, including animals, plants, and microorganisms. It is especially abundant in tissues with high metabolic activity, such as the liver and blood. (Review)

Dietary catalase is present in foods such as fruits and vegetables, but its contribution to systemic catalase activity is not well established due to enzyme degradation during digestion. Industrially, catalase used in research or formulations is typically derived from microbial or animal sources. (Review)

How It Behaves in the Body

Catalase works by rapidly converting hydrogen peroxide—a reactive and potentially damaging molecule—into water and oxygen. In simple terms, it acts like a cleanup system that prevents harmful buildup of oxidative substances inside cells. (Review)

At the biochemical level, catalase operates in cellular structures called peroxisomes, where it neutralizes hydrogen peroxide generated during metabolic processes. This function is part of a broader antioxidant network that includes enzymes like superoxide dismutase. (Review)

While its enzymatic role is well established, translating this function into clinical outcomes through supplementation or topical use remains an area of ongoing research with limited human evidence.

Absorption & Delivery Formats

  • Oral: Limited evidence; enzymes like catalase are likely degraded in digestion
  • Topical: Most studied format, especially in dermatology research
  • Injectable: Not commonly used in human studies

Topical delivery has been the primary route studied in humans, particularly in combination with UV therapies. Evidence for systemic delivery remains limited.

Quick Facts at a Glance

  • Onset (reported): Repigmentation effects in vitiligo studies typically observed over months when present. (Research)
  • Time to peak (Tmax): Not well characterized in human studies
  • Half-life (t½): Not well established for exogenous use
  • Typical duration: Studies often range from several weeks to 6 months in dermatology contexts. (Research)
  • Absorption routes studied: Primarily topical application
  • Formulation differences: Pseudocatalase and combination antioxidant gels show variable outcomes. (Research)
  • Variability drivers: Disease severity, combination therapy, and UV exposure
  • Tolerance / adaptation: Limited data
  • Evidence strength snapshot: Limited and condition-specific

Safety, Interactions & Regulation

Catalase has been used in topical formulations in clinical studies with no major safety concerns reported, although formal safety profiling is limited. (Research)

There is limited human data on systemic administration or long-term exposure, and most safety information comes from its endogenous role rather than supplementation studies. (Review)

In the United States, catalase is not approved by the FDA as a drug for medical use and is primarily treated as a biochemical or research substance rather than a regulated therapeutic agent.

In the European Union, catalase is not established as a medicinal product for clinical use, though it may appear in certain cosmetic or industrial contexts depending on formulation and use case.

Evidence Overview

The human evidence base for catalase is narrow and primarily concentrated in dermatological research, especially vitiligo. Clinical studies include randomized controlled trials, pilot studies, and observational research, with a strong focus on topical formulations and combination therapies rather than isolated catalase interventions. (Research)

The strongest and most consistent findings relate to altered catalase activity in disease states, particularly reduced levels in individuals with vitiligo. These findings come from observational and case-control studies, suggesting a role for oxidative stress imbalance in disease mechanisms. (Research)

Interventional studies show mixed results. Some uncontrolled or small studies report repigmentation improvements with catalase-containing therapies, while randomized controlled trials have failed to demonstrate clear added benefit over standard treatments such as UVB therapy alone. (Research) (Research)

A key limitation of the evidence base is that catalase is rarely studied in isolation. Most interventions combine catalase with other antioxidants or treatments, making it difficult to determine its independent effects. Additionally, sample sizes are often small, and study designs vary significantly.

Overall, while catalase is biologically well understood as an antioxidant enzyme, its translation into clinical outcomes in humans remains uncertain and limited to specific conditions.

Evidence Confidence Classification

The overall human evidence for catalase is best classified as Limited / Mixed, based on a small number of human studies with inconsistent findings and a strong reliance on combination therapies rather than isolated interventions. (Research)

This classification reflects the presence of some randomized trials and observational studies, but with variability in outcomes and limited generalizability beyond dermatology. (Research)

Similar Ingredients & Comparators

Similar supplement-style ingredients:

  • Superoxide dismutase
  • Glutathione
  • N-acetylcysteine
  • Vitamin C
  • Vitamin E
  • Coenzyme Q10
  • Alpha-lipoic acid

Medical / pharma comparator categories:

  • Topical corticosteroids
  • Phototherapy (UVB)
  • Antioxidant therapies

Combination Context

Catalase + Superoxide Dismutase:
Studied in topical formulations for vitiligo, where combined antioxidant activity may support reduction of oxidative stress; results are variable and often based on small studies. (Research)

Catalase + Narrowband UVB:
Evaluated in randomized trials for vitiligo; UVB shows effectiveness, but catalase addition does not consistently improve outcomes. (Research)

Catalase + Calcium (pseudocatalase systems):
Early studies combined pseudocatalase with calcium and UV exposure, reporting repigmentation, though these findings were not consistently replicated in later trials. (Research)

FAQ

What is catalase?
Catalase is an antioxidant enzyme naturally produced in the body that breaks down hydrogen peroxide into water and oxygen. (Review)
It plays a key role in protecting cells from oxidative damage caused by reactive oxygen species. (Review)

What does human research study it for?
Human research primarily studies catalase in the context of skin conditions such as vitiligo and oxidative stress-related pathways. (Research)
Most studies examine either endogenous catalase levels or topical formulations used alongside other treatments. (Research)

What are the best-supported uses?
The strongest human evidence relates to catalase as a biomarker and pathway component in vitiligo. (Research)
Interventional uses show mixed results and are not consistently supported across studies. (Research)

Where is evidence mixed or limited?
Evidence is mixed for topical catalase therapies in vitiligo, with some studies reporting improvement and others no effect. (Research)
Outside dermatology, human evidence is limited and largely based on mechanistic research. (Review)

How quickly does it act (onset)?
In studies where effects are observed, such as repigmentation in vitiligo, changes typically occur over several months. (Research)
There is no well-defined onset for systemic effects in humans.

What affects absorption and variability?
Topical formulation, combination therapies, and exposure to UV light can influence outcomes in dermatology studies. (Research)
For oral intake, enzyme degradation in digestion may limit absorption. (Review)

Is tolerance reported?
There is limited data on tolerance or adaptation with catalase use in humans. (Review)

Why do studies disagree?
Differences in study design, small sample sizes, and the use of combination therapies contribute to inconsistent findings. (Research)

What ingredients is it commonly combined with and why?
Catalase is often combined with antioxidants such as superoxide dismutase or used alongside UV therapy to target oxidative stress pathways. (Research)

What foods naturally contain this ingredient?
Catalase is present in many plant and animal foods, but its functional contribution after digestion is unclear. (Review)

How is it regulated?
Catalase is not approved as a drug by the FDA and is not widely regulated as a therapeutic agent.
In the EU, it is not established as a medicinal product for clinical use.

Resources

No Result
View All Result

© 2026 SHIZAM Limited. All rights reserved.